Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease

Shunsuke Chikuma, Jeffrey A. Bluestone

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Both CTLA-4-deficient and FoxP3-deficient mice exhibit a short life span due to massive lymphoproliferation (LP) and a systemic autoimmune-like syndrome. Although it has been postulated that both diseases result from regulatory T cell (Treg) defects, there have been no direct complementation studies to elucidate their relationship in homeostatic lymphocyte proliferation during the neonatal period. In this study, reconstitution of sublethally irradiated RAG KO mice with either CTLA-4-deficient or FoxP3-deficient bone marrow (BM) resulted in LP disease similar to that observed in CTLA-4 KO or Scurfy mice, respectively. Although co-injection of BM from wild-type mice inhibited the activation of CTLA-4-deficient or FoxP3-deficient T cells and ameliorated LP disease through extrinsic regulatory mechanisms by Treg cells, mice that had received the BM mixture of Scurfy and CTLA-4 KO BM eventually died of incomplete protection. These results suggest common attributes of both diseases, but expression of both CTLA-4 and FoxP3 on the same cell subset is essential to fully prevent LP disease.

Original languageEnglish
Pages (from-to)1285-1289
Number of pages5
JournalEuropean Journal of Immunology
Volume37
Issue number5
DOIs
Publication statusPublished - 2007 May
Externally publishedYes

Fingerprint

Bone Marrow
Regulatory T-Lymphocytes
Disease Attributes
Lymphocytes
T-Lymphocytes
Injections

Keywords

  • Autoimmunity
  • Costimulation
  • Tolerance

ASJC Scopus subject areas

  • Immunology

Cite this

Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. / Chikuma, Shunsuke; Bluestone, Jeffrey A.

In: European Journal of Immunology, Vol. 37, No. 5, 05.2007, p. 1285-1289.

Research output: Contribution to journalArticle

@article{fa2589b4c2c44957ad16fdcb89128a2d,
title = "Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease",
abstract = "Both CTLA-4-deficient and FoxP3-deficient mice exhibit a short life span due to massive lymphoproliferation (LP) and a systemic autoimmune-like syndrome. Although it has been postulated that both diseases result from regulatory T cell (Treg) defects, there have been no direct complementation studies to elucidate their relationship in homeostatic lymphocyte proliferation during the neonatal period. In this study, reconstitution of sublethally irradiated RAG KO mice with either CTLA-4-deficient or FoxP3-deficient bone marrow (BM) resulted in LP disease similar to that observed in CTLA-4 KO or Scurfy mice, respectively. Although co-injection of BM from wild-type mice inhibited the activation of CTLA-4-deficient or FoxP3-deficient T cells and ameliorated LP disease through extrinsic regulatory mechanisms by Treg cells, mice that had received the BM mixture of Scurfy and CTLA-4 KO BM eventually died of incomplete protection. These results suggest common attributes of both diseases, but expression of both CTLA-4 and FoxP3 on the same cell subset is essential to fully prevent LP disease.",
keywords = "Autoimmunity, Costimulation, Tolerance",
author = "Shunsuke Chikuma and Bluestone, {Jeffrey A.}",
year = "2007",
month = "5",
doi = "10.1002/eji.200737159",
language = "English",
volume = "37",
pages = "1285--1289",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "5",

}

TY - JOUR

T1 - Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease

AU - Chikuma, Shunsuke

AU - Bluestone, Jeffrey A.

PY - 2007/5

Y1 - 2007/5

N2 - Both CTLA-4-deficient and FoxP3-deficient mice exhibit a short life span due to massive lymphoproliferation (LP) and a systemic autoimmune-like syndrome. Although it has been postulated that both diseases result from regulatory T cell (Treg) defects, there have been no direct complementation studies to elucidate their relationship in homeostatic lymphocyte proliferation during the neonatal period. In this study, reconstitution of sublethally irradiated RAG KO mice with either CTLA-4-deficient or FoxP3-deficient bone marrow (BM) resulted in LP disease similar to that observed in CTLA-4 KO or Scurfy mice, respectively. Although co-injection of BM from wild-type mice inhibited the activation of CTLA-4-deficient or FoxP3-deficient T cells and ameliorated LP disease through extrinsic regulatory mechanisms by Treg cells, mice that had received the BM mixture of Scurfy and CTLA-4 KO BM eventually died of incomplete protection. These results suggest common attributes of both diseases, but expression of both CTLA-4 and FoxP3 on the same cell subset is essential to fully prevent LP disease.

AB - Both CTLA-4-deficient and FoxP3-deficient mice exhibit a short life span due to massive lymphoproliferation (LP) and a systemic autoimmune-like syndrome. Although it has been postulated that both diseases result from regulatory T cell (Treg) defects, there have been no direct complementation studies to elucidate their relationship in homeostatic lymphocyte proliferation during the neonatal period. In this study, reconstitution of sublethally irradiated RAG KO mice with either CTLA-4-deficient or FoxP3-deficient bone marrow (BM) resulted in LP disease similar to that observed in CTLA-4 KO or Scurfy mice, respectively. Although co-injection of BM from wild-type mice inhibited the activation of CTLA-4-deficient or FoxP3-deficient T cells and ameliorated LP disease through extrinsic regulatory mechanisms by Treg cells, mice that had received the BM mixture of Scurfy and CTLA-4 KO BM eventually died of incomplete protection. These results suggest common attributes of both diseases, but expression of both CTLA-4 and FoxP3 on the same cell subset is essential to fully prevent LP disease.

KW - Autoimmunity

KW - Costimulation

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=34250305462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250305462&partnerID=8YFLogxK

U2 - 10.1002/eji.200737159

DO - 10.1002/eji.200737159

M3 - Article

C2 - 17429849

AN - SCOPUS:34250305462

VL - 37

SP - 1285

EP - 1289

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 5

ER -